Given the reduced APOO expression in CCR7+(Sub2) cells from ITP patients, this downregulation may contribute to SP100 upregulation and subsequent activation of FOXP1 and CDK6. The gene discussed is SP100; the disease is autoimmune thrombocytopenic purpura.